A recently described master regulator protein may explain the development of aberrant cell growth in the pancreas spurred by inflammation. The team profiled gene expression of mouse pancreatic ductal and duct-like cells from different states — embryonic development, acute pancreatitis and K-ras mutation-driven carcinogenesis — to find the molecular regulation of these processes.